Sergii Pavlov

Prof. Sergii Pavlov

Zaporizhia State Medical University, Zaporizhia, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Sergii PavlovSergii Pavlov
Sergii Pavlov
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
The study of mitochondrial dysfunction has become increasingly pivotal in elucidating the pathophysiology of various cerebral pathologies, particularly neurodegenerative disorders. Mitochondria are essential for cellular energy metabolism, regulation of reactive oxygen species (ROS), calcium homeostasis, and the execution of apoptotic processes. Disruptions in mitochondrial function, driven by factors such as oxidative stress, excitotoxicity, and altered ion balance, lead to neuronal death and contribute to cognitive impairments in several brain diseases. Mitochondrial dysfunction can arise from genetic mutations, ischemic events, hypoxia, and other environmental factors. This article highlights the critical role of mitochondrial dysfunction in the progression of neurodegenerative diseases and discusses the need for targeted therapeutic strategies to attenuate cellular damage, restore mitochondrial function, and enhance neuroprotection.

1 July 2012 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
IBIgor Belenichev
Igor Belenichev
OOO. V. Odnokoz
O. V. Odnokoz
Sergii PavlovSergii Pavlov
Sergii Pavlov
OBO. I. Belenicheva
O. I. Belenicheva
EPE. N. Polyakova
E. N. Polyakova
Modulators of estrogen receptors play a significant role in cerebral activity and in the regulation of vital functions of the whole organisms. This work objective is to enlarge knowledge of Tamoxifen...

14 March 2012 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
IBIgor Belenichev
Igor Belenichev
YKYu. M. Kolesnik
Yu. M. Kolesnik
Sergii PavlovSergii Pavlov
Sergii Pavlov
ESE. P. Sokolik
E. P. Sokolik
NBN. V. Bukhtiyarova
N. V. Bukhtiyarova
Acute or chronic brain ischemia induces a cascade of pathobiochemical reactions that finally result in the development of focal neurological deficit, dyscirculatory encephalopathy, or the death of a...

8 November 2023 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
TBTatyana A Berezina
Tatyana A Berezina
IFIvan M. Fushtey
Ivan M. Fushtey
Sergii PavlovSergii Pavlov
Sergii Pavlov
Alexander E. BerezinAlexander E. Berezin
Alexander E. Berezin
Introduction Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have a favorable impact on the kidney function in patients with heart failure (HF), while there is no clear evidence of what factors predict this effect. The aim of the study was to identify plausible predictors for kidney function outcome among patients with HF and investigate their association with SGLT2i. Methods We prospectively enrolled 480 patients with type 2 diabetes mellitus (T2DM) treated with diet and metformin and concomitant chronic HF and followed them for 52 weeks. In the study, we determined kidney outcome as a composite of ≥ 40% reduced estimated glomerular filtration rate from baseline, newly diagnosed end-stage kidney disease or kidney replacement therapy. The relevant medical information and measurement of the biomarkers (N-terminal natriuretic pro-peptide, irisin, apelin, adropin, C-reactive protein, tumor necrosis factor-alpha) were collected at baseline and at the end of the study. Results The composite kidney outcome was detected in 88 (18.3%) patients of the entire population. All patients received guideline-recommended optimal therapy, which was adjusted to phenotype/severity of HF, cardiovascular risk and comorbidity profiles, and fasting glycemia. Levels of irisin, adropin and apelin significantly increased in patients without clinical endpoint, whereas in those with composite endpoint the biomarker levels exhibited a decrease with borderline statistical significance (p = 0.05). We noticed that irisin ≤ 4.50 ng/ml at baseline and a ≤ 15% increase in irisin serum levels added more valuable predictive information than the reference variable. However, the combination of irisin ≤ 4.50 ng/ml at baseline and ≤ 15% increase in irisin serum levels (area under curve = 0.91; 95% confidence interval = 0.87–0.95) improved the discriminative value of each biomarker alone. Conclusion We suggest that low levels of irisin and its inadequate increase during administration of SGLT2i are promising predictors for unfavorable kidney outcome among patients with T2DM and concomitant HF.

7 December 2011 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
IBIgor Belenichev
Igor Belenichev
YKYu. M. Kolesnik
Yu. M. Kolesnik
Sergii PavlovSergii Pavlov
Sergii Pavlov
ESE. P. Sokolik
E. P. Sokolik
NBN. V. Bukhtiyarova
N. V. Bukhtiyarova
We studied the involvement of HSP70 and Hif1b genes in the development of pathological changes in the brains of experimental animals during ischemia. We found neuro- and mitoprotective...

Verified
Journal Article
Open access
PDF file
EBElke Boxhammer
Elke Boxhammer
Alexander E. BerezinAlexander E. Berezin
Alexander E. Berezin
VPVera Paar
Vera Paar
NBNina Bacher
Nina Bacher
ATAlbert Topf
Albert Topf
Michael LichtenauerMichael Lichtenauer
Michael Lichtenauer
Patients with severe aortic valve stenosis and concomitant pulmonary hypertension show a significantly reduced survival prognosis. Right heart catheterization as a preoperative diagnostic tool to determine pulmonary hypertension has been largely abandoned in recent years in favor of echocardiographic criteria. Clinically, determination of echocardiographically estimated systolic pulmonary artery pressure falls far short of invasive right heart catheterization data in terms of accuracy. The aim of the present systematic review was to highlight noninvasive possibilities for the detection of pulmonary hypertension in patients with severe aortic valve stenosis, with a special focus on cardiovascular biomarkers. A total of 525 publications regarding echocardiography, cardiovascular imaging and biomarkers related to severe aortic valve stenosis and pulmonary hypertension were analyzed in a systematic database analysis using PubMed Central®. Finally, 39 publications were included in the following review. It was shown that the current scientific data situation, especially regarding cardiovascular biomarkers as non-invasive diagnostic tools for the determination of pulmonary hypertension in severe aortic valve stenosis patients, is poor. Thus, there is a great scientific potential to combine different biomarkers (biomarker scores) in a non-invasive way to determine the presence or absence of PH.